+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Etravirine Market by Dosage Form (Film-Coated Tablet), Competition Type (Branded, Generic), Packaging, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Etravirine Market by Dosage Form (Film-Coated Tablet), Competition Type (Branded, Generic), Packaging, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Etravirine Market by Dosage Form (Film-Coated Tablet), Competition Type (Branded, Generic), Packaging, End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015385
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Etravirine market remains a pivotal segment within HIV antiretroviral therapy, shaped by evolving treatment protocols, market access challenges, and ongoing technological advancements. Senior decision-makers are navigating this dynamic environment, seeking clear context and actionable insights to support sustainable growth and competitive positioning.

Market Snapshot: Etravirine Market Size and Growth

The Etravirine Market grew from USD 257.34 million in 2024 to USD 266.59 million in 2025. It is expected to continue growing at a CAGR of 3.53%, reaching USD 316.89 million by 2030.

Scope & Market Segmentation for Etravirine

  • Dosage Forms: Film-coated tablets designed for enhanced drug stability and patient adherence.
  • Competition Types: Branded pharmaceuticals and generics, including both approved and authorized generic variants.
  • Packaging: Blister packs favored for institutional use; bottles available in counts of 30 or 60 tablets for flexible dispensing.
  • End Users: Ambulatory care centers, clinics (public and private), home care settings, and hospitals (public and private).
  • Distribution Channels: Hospital pharmacy networks, online pharmacies (through mobile apps and websites), and retail pharmacies serving both community and institutional sectors.
  • Regional Markets: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (expanding across key markets from the United Kingdom to Saudi Arabia and South Africa), and Asia-Pacific (spanning China, India, Japan, Australia, and Southeast Asia).
  • Leading Industry Stakeholders: Companies such as Johnson & Johnson, Viatris Inc., Teva Pharmaceutical Industries Limited, Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Limited, Hetero Healthcare Limited, Sun Pharmaceutical Industries Limited, Lupin Limited, and Sandoz International GmbH play vital roles in research, production, and distribution.

Key Takeaways for Senior Decision-Makers

  • Etravirine’s unique profile as a second-generation non-nucleoside reverse transcriptase inhibitor positions it at the forefront of resistance-guided HIV therapy strategies.
  • Technological advancements in formulation, including potential long-acting injectables and integration with digital health tools, are influencing adherence and patient outcomes.
  • Value-based care models and comprehensive health economic evaluations are increasingly shaping payer negotiations and influencing regional procurement strategies.
  • The growing presence of generics and authorized generics introduces nuanced competition, requiring flexible licensing and differentiation in both branded and generic spheres.
  • Regional regulatory differences and diverse reimbursement mechanisms necessitate tailored market entry and supply strategies to meet unique local requirements.

Tariff Impact and Supply Chain Considerations

With revised tariffs in the United States effective from 2025, stakeholders are reassessing supply chain logistics and pricing paradigms. Tariffs on imported active pharmaceutical ingredients are prompting manufacturers to negotiate mitigation clauses and explore localized production to minimize input cost volatility. Market players are also refining inventory management, entering long-term procurement contracts, and developing risk-sharing agreements to address pricing pressures while maintaining uninterrupted product supply.

Methodology & Data Sources

This report employs a multi-source intelligence approach, combining primary interviews with opinion leaders and regulatory authorities, and in-depth secondary research from peer-reviewed journals, clinical trial data, and corporate disclosures. Analytical rigor is reinforced through data triangulation and expert review for accuracy and relevance.

Why This Report Matters

  • Enables stakeholders to benchmark competitive positioning and anticipate regulatory or supply chain shifts affecting sustainable market access.
  • Equips decision-makers with actionable segmentation data supporting regional targeting and product development, aligned with changing reimbursement and pricing strategies.
  • Delivers strategic context on partnerships, innovation pathways, and the implications of emerging tariffs—supporting robust short- and long-term planning.

Conclusion

Etravirine’s evolving market landscape reflects the intersection of technological progress, regulatory response, and supply chain adaptation. Informed stakeholders can leverage these insights to reinforce resilience, optimize strategies, and improve patient access throughout diverse markets.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of etravirine in heavily treatment-experienced HIV patients with resistance profiles
5.2. Comparative cost effectiveness of generic versus branded etravirine formulations in emerging markets
5.3. Impact of new long term safety and tolerability data on clinician preference for etravirine in ART regimens
5.4. Integration of etravirine into once daily fixed dose combinations to enhance patient adherence rates
5.5. Regulatory approvals and label expansions driving etravirine uptake across Latin America and Southeast Asia
5.6. Development and launch of pediatric etravirine formulations to address HIV infection in children globally
5.7. Influence of drug-drug interaction profile of etravirine on prescribing patterns in polypharmacy populations
5.8. Real world evidence demonstrating etravirine efficacy and tolerability in aging HIV positive patients with comorbidities
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Etravirine Market, by Dosage Form
8.1. Introduction
8.2. Film-Coated Tablet
9. Etravirine Market, by Competition Type
9.1. Introduction
9.2. Branded
9.3. Generic
9.3.1. Approved Generic
9.3.2. Authorized Generic
10. Etravirine Market, by Packaging
10.1. Introduction
10.2. Blister Pack
10.3. Bottles
10.3.1. 30 Tablets
10.3.2. 60 Tablets
11. Etravirine Market, by End User
11.1. Introduction
11.2. Ambulatory Care
11.3. Clinics
11.3.1. Private Clinic
11.3.2. Public Clinic
11.4. Home Care
11.5. Hospitals
11.5.1. Private Hospital
11.5.2. Public Hospital
12. Etravirine Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.3.1. Mobile App
12.3.2. Website
12.4. Retail Pharmacy
13. Americas Etravirine Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Etravirine Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Etravirine Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Johnson & Johnson
16.3.2. Viatris Inc.
16.3.3. Teva Pharmaceutical Industries Limited
16.3.4. Cipla Limited
16.3.5. Aurobindo Pharma Limited
16.3.6. Dr. Reddy’s Laboratories Limited
16.3.7. Hetero Healthcare Limited
16.3.8. Sun Pharmaceutical Industries Limited
16.3.9. Lupin Limited
16.3.10. Sandoz International GmbH
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ETRAVIRINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ETRAVIRINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ETRAVIRINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ETRAVIRINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ETRAVIRINE MARKET SIZE, BY PACKAGING, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ETRAVIRINE MARKET SIZE, BY PACKAGING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ETRAVIRINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ETRAVIRINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ETRAVIRINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ETRAVIRINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ETRAVIRINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ETRAVIRINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ETRAVIRINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ETRAVIRINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ETRAVIRINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ETRAVIRINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ETRAVIRINE MARKET: RESEARCHAI
FIGURE 26. ETRAVIRINE MARKET: RESEARCHSTATISTICS
FIGURE 27. ETRAVIRINE MARKET: RESEARCHCONTACTS
FIGURE 28. ETRAVIRINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ETRAVIRINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ETRAVIRINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ETRAVIRINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ETRAVIRINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ETRAVIRINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ETRAVIRINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ETRAVIRINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ETRAVIRINE MARKET SIZE, BY FILM-COATED TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ETRAVIRINE MARKET SIZE, BY FILM-COATED TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ETRAVIRINE MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ETRAVIRINE MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ETRAVIRINE MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ETRAVIRINE MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ETRAVIRINE MARKET SIZE, BY APPROVED GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ETRAVIRINE MARKET SIZE, BY APPROVED GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ETRAVIRINE MARKET SIZE, BY AUTHORIZED GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ETRAVIRINE MARKET SIZE, BY AUTHORIZED GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ETRAVIRINE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ETRAVIRINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ETRAVIRINE MARKET SIZE, BY BLISTER PACK, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ETRAVIRINE MARKET SIZE, BY BLISTER PACK, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ETRAVIRINE MARKET SIZE, BY BOTTLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ETRAVIRINE MARKET SIZE, BY BOTTLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ETRAVIRINE MARKET SIZE, BY 30 TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ETRAVIRINE MARKET SIZE, BY 30 TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ETRAVIRINE MARKET SIZE, BY 60 TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ETRAVIRINE MARKET SIZE, BY 60 TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ETRAVIRINE MARKET SIZE, BY BOTTLES, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ETRAVIRINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ETRAVIRINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ETRAVIRINE MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ETRAVIRINE MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ETRAVIRINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ETRAVIRINE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ETRAVIRINE MARKET SIZE, BY PRIVATE CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ETRAVIRINE MARKET SIZE, BY PRIVATE CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ETRAVIRINE MARKET SIZE, BY PUBLIC CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ETRAVIRINE MARKET SIZE, BY PUBLIC CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ETRAVIRINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ETRAVIRINE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ETRAVIRINE MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ETRAVIRINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ETRAVIRINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ETRAVIRINE MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ETRAVIRINE MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ETRAVIRINE MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ETRAVIRINE MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ETRAVIRINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ETRAVIRINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ETRAVIRINE MARKET SIZE, BY MOBILE APP, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ETRAVIRINE MARKET SIZE, BY MOBILE APP, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ETRAVIRINE MARKET SIZE, BY WEBSITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ETRAVIRINE MARKET SIZE, BY WEBSITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ETRAVIRINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ETRAVIRINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ETRAVIRINE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ETRAVIRINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ETRAVIRINE MARKET SIZE, BY BOTTLES, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ETRAVIRINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ETRAVIRINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ETRAVIRINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ETRAVIRINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ETRAVIRINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ETRAVIRINE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES ETRAVIRINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES ETRAVIRINE MARKET SIZE, BY BOTTLES, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES ETRAVIRINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES ETRAVIRINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES ETRAVIRINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ETRAVIRINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ETRAVIRINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 117. CANADA ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 118. CANADA ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 119. CANADA ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2024 (USD MILLION)
TABLE 120. CANADA ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2025-2030 (USD MILLION)
TABLE 121. CANADA ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 122. CANADA ETRAVIRINE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 123. CANADA ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 124. CANADA ETRAVIRINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 125. CANADA ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
TABLE 126. CANADA ETRAVIRINE MARKET SIZE, BY BOTTLES, 2025-2030 (USD MILLION)
TABLE 127. CANADA ETRAVIRINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. CANADA ETRAVIRINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. CANADA ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 130. CANADA ETRAVIRINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 131. CANADA ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 132. CANADA ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 133. CANADA ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. CANADA ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. CANADA ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 136. CANADA ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 137. MEXICO ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 138. MEXICO ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 139. MEXICO ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2024 (USD MILLION)
TABLE 140. MEXICO ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2025-2030 (USD MILLION)
TABLE 141. MEXICO ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 142. MEXICO ETRAVIRINE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 143. MEXICO ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 144. MEXICO ETRAVIRINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 145. MEXICO ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
TABLE 146. MEXICO ETRAVIRINE MARKET SIZE, BY BOTTLES, 2025-2030 (USD MILLION)
TABLE 147. MEXICO ETRAVIRINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. MEXICO ETRAVIRINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. MEXICO ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 150. MEXICO ETRAVIRINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 151. MEXICO ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 152. MEXICO ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 153. MEXICO ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. MEXICO ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. MEXICO ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 156. MEXICO ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL ETRAVIRINE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL ETRAVIRINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL ETRAVIRINE MARKET SIZE, BY BOTTLES, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL ETRAVIRINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL ETRAVIRINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL ETRAVIRINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA ETRAVIRINE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA ETRAVIRINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA ETRAVIRINE MARKET SIZE, BY BOTTLES, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA ETRAVIRINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA ETRAVIRINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA ETRAVIRINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY BOTTLES, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM ETRAVIRINE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM ETRAVIRINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM ETRAVIRINE MARKET SIZE, BY BOTTLES, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM ETRAVIRINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM ETRAVIRINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM ETRAVIRINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 239. GERMANY ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 240. GERMANY ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 241. GERMANY ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2024 (USD MILLION)
TABLE 242. GERMANY ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2025-2030 (USD MILLION)
TABLE 243. GERMANY ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 244. GERMANY ETRAVIRINE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 245. GERMANY ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 246. GERMANY ETRAVIRINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 247. GERMANY ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
TABLE 248. GERMANY ETRAVIRINE MARKET SIZE, BY BOTTLES, 2025-2030 (USD MILLION)
TABLE 249. GERMANY ETRAVIRINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. GERMANY ETRAVIRINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. GERMANY ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 252. GERMANY ETRAVIRINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 253. GERMANY ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 254. GERMANY ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 255. GERMANY ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. GERMANY ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. GERMANY ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 258. GERMANY ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 259. FRANCE ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 260. FRANCE ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 261. FRANCE ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2024 (USD MILLION)
TABLE 262. FRANCE ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2025-2030 (USD MILLION)
TABLE 263. FRANCE ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 264. FRANCE ETRAVIRINE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 265. FRANCE ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 266. FRANCE ETRAVIRINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 267. FRANCE ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
TABLE 268. FRANCE ETRAVIRINE MARKET SIZE, BY BOTTLES, 2025-2030 (USD MILLION)
TABLE 269. FRANCE ETRAVIRINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. FRANCE ETRAVIRINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. FRANCE ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 272. FRANCE ETRAVIRINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 273. FRANCE ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 274. FRANCE ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 275. FRANCE ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. FRANCE ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. FRANCE ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 278. FRANCE ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA ETRAVIRINE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA ETRAVIRINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA ETRAVIRINE MARKET SIZE, BY BOTTLES, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA ETRAVIRINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA ETRAVIRINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA ETRAVIRINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 299. ITALY ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 300. ITALY ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 301. ITALY ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2024 (USD MILLION)
TABLE 302. ITALY ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2025-2030 (USD MILLION)
TABLE 303. ITALY ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 304. ITALY ETRAVIRINE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 305. ITALY ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 306. ITALY ETRAVIRINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 307. ITALY ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
TABLE 308. ITALY ETRAVIRINE MARKET SIZE, BY BOTTLES, 2025-2030 (USD MILLION)
TABLE 309. ITALY ETRAVIRINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. ITALY ETRAVIRINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. ITALY ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 312. ITALY ETRAVIRINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 313. ITALY ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 314. ITALY ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 315. ITALY ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. ITALY ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. ITALY ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 318. ITALY ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 319. SPAIN ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 320. SPAIN ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 321. SPAIN ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2024 (USD MILLION)
TABLE 322. SPAIN ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2025-2030 (USD MILLION)
TABLE 323. SPAIN ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 324. SPAIN ETRAVIRINE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 325. SPAIN ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 326. SPAIN ETRAVIRINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 327. SPAIN ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
TABLE 328. SPAIN ETRAVIRINE MARKET SIZE, BY BOTTLES, 2025-2030 (USD MILLION)
TABLE 329. SPAIN ETRAVIRINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. SPAIN ETRAVIRINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 331. SPAIN ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 332. SPAIN ETRAVIRINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 333. SPAIN ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 334. SPAIN ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 335. SPAIN ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 336. SPAIN ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 337. SPAIN ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 338. SPAIN ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 339. UNITED ARAB EMIRATES ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 340. UNITED ARAB EMIRATES ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 341. UNITED ARAB EMIRATES ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2024 (USD MILLION)
TABLE 342. UNITED ARAB EMIRATES ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2025-2030 (USD MILLION)
TABLE 343. UNITED ARAB EMIRATES ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 344. UNITED ARAB EMIRATES ETRAVIRINE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 345. UNITED ARAB EMIRATES ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 346. UNITED ARAB EMIRATES ETRAVIRINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 347. UNITED ARAB EMIRATES ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
TABLE 348. UNITED ARAB EMIRATES ETRAVIRINE MARKET SIZE, BY BOTTLES, 2025-2030 (USD MILLION)
TABLE 349. UNITED ARAB EMIRATES ETRAVIRINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 350. UNITED ARAB EMIRATES ETRAVIRINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 351. UNITED ARAB EMIRATES ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 352. UNITED ARAB EMIRATES ETRAVIRINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 353. UNITED ARAB EMIRATES ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 354. UNITED ARAB EMIRATES ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 355. UNITED ARAB EMIRATES ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 356. UNITED ARAB EMIRATES ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 357. UNITED ARAB EMIRATES ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 358. UNITED ARAB EMIRATES ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 359. SAUDI ARABIA ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 360. SAUDI ARABIA ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 361. SAUDI ARABIA ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2024 (USD MILLION)
TABLE 362. SAUDI ARABIA ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2025-2030 (USD MILLION)
TABLE 363. SAUDI ARABIA ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2024 (USD MILLION)
TABLE 364. SAUDI ARABIA ETRAVIRINE MARKET SIZE, BY GENERIC, 2025-2030 (USD MILLION)
TABLE 365. SAUDI ARABIA ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 366. SAUDI ARABIA ETRAVIRINE MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 367. SAUDI ARABIA ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
TABLE 368. SAUDI ARABIA ETRAVIRINE MARKET SIZE, BY BOTTLES, 2025-2030 (USD MILLION)
TABLE 369. SAUDI ARABIA ETRAVIRINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 370. SAUDI ARABIA ETRAVIRINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 371. SAUDI ARABIA ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 372. SAUDI ARABIA ETRAVIRINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 373. SAUDI ARABIA ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 374. SAUDI ARABIA ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 375. SAUDI ARABIA ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 376. SAUDI ARABIA ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 377. SAUDI ARABIA ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 378. SAUDI ARABIA ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 379. SOUTH AFRICA ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 380. SOUTH AFRICA ETRAVIRINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 381. SOUTH AFRICA ETRAVIRINE MARKET SIZE, B

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Etravirine market report include:
  • Johnson & Johnson
  • Viatris Inc.
  • Teva Pharmaceutical Industries Limited
  • Cipla Limited
  • Aurobindo Pharma Limited
  • Dr. Reddy’s Laboratories Limited
  • Hetero Healthcare Limited
  • Sun Pharmaceutical Industries Limited
  • Lupin Limited
  • Sandoz International GmbH

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 266.59 Million
Forecasted Market Value ( USD ) by 2030 $ 316.89 Million
Compound Annual Growth Rate3.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Etravirine (CAS 269055-15-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Etravirine (CAS 269055-15-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Human Immunodeficiency Virus Therapeutics Market by Drug Class, Regimen Type, Therapy Line, Mode Of Administration, Patient Type, Distribution Channel - Global Forecast 2025-2030 - Product Image

Human Immunodeficiency Virus Therapeutics Market by Drug Class, Regimen Type, Therapy Line, Mode Of Administration, Patient Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
HIV Clinical Trials Market by Drug Class, Trial Phase, End User, Route Of Administration, Distribution Channel, Patient Age Group - Global Forecast 2025-2030 - Product Image

HIV Clinical Trials Market by Drug Class, Trial Phase, End User, Route Of Administration, Distribution Channel, Patient Age Group - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
HIV Drugs Market Report 2025 - Product Image

HIV Drugs Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Lychee Syrup Market Size, Share & Trends Analysis Report By Nature (Organic, Conventional), By Packaging (Bottles, Cans), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Lychee Syrup Market Size, Share & Trends Analysis Report By Nature (Organic, Conventional), By Packaging (Bottles, Cans), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 90 Pages
  • Global
From

About the Etravirine Market

Etravirine is an antiretroviral drug used to treat HIV/AIDS. It is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that works by blocking the action of the HIV-1 reverse transcriptase enzyme, which is responsible for the replication of the virus. Etravirine is used in combination with other antiretroviral drugs to treat HIV-1 infection in adults and adolescents over the age of 12. It is also used to treat HIV-1 infection in adults and adolescents over the age of 12 who have already been treated with other antiretroviral drugs. Etravirine is available in tablet form and is taken orally. It is usually taken twice daily with food. Common side effects of etravirine include nausea, headache, and dizziness. More serious side effects may include liver problems, changes in body fat, and changes in the immune system. Etravirine is marketed by several pharmaceutical companies, including Janssen Pharmaceuticals, Merck & Co., and Tibotec Pharmaceuticals. It is also available in generic form from several generic drug manufacturers. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.